Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 15, 2020 9:00 A.M.
Form: S-4
CIK: 0001743881
Company Name: BridgeBio Pharma, Inc.
File Number: 333-249944